uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Cash from Investing Activities (2016 - 2026)

uniQure (QURE) posted quarterly Cash from Investing Activities of $53.3 million for Q2 2026, down 27.12% year-over-year from $73.1 million in Q2 2025, and down 45.96% quarter-over-quarter from $98.6 million in Q1 2026.

Analysis

uniQure (QURE) Cash from Investing Activities (2016 - 2026) Analysis & Trends

uniQure's Cash from Investing Activities history runs 11 years deep, the most recent figure standing at $53.3 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 27.12% year-over-year to $53.3 million; the TTM figure through Jun 2026 stood at -$263.0 million (down 330.24% YoY), while the FY2025 annual figure was -$321.6 million, down 297.35% from the prior year.
  • Cash from Investing Activities for Q2 2026 stood at $53.3 million, down from $98.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $98.6 million in Q1 2026, with the low at -$441.4 million in Q4 2025.
  • The 5-year median for Cash from Investing Activities is $23.3 million (2025), against an average of -$22.0 million.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 6103.16% in 2023, then surged 2041.4% in 2024.
  • uniQure's Cash from Investing Activities stood at -$168.2 million in 2022, then surged by 135.41% to $59.6 million in 2023, then tumbled by 144.7% to -$26.6 million in 2024, then sank by 1557.79% to -$441.4 million in 2025, then soared by 112.07% to $53.3 million in 2026.
  • Business Quant data shows QURE's Cash from Investing Activities at $53.3 million in Q2 2026, $98.6 million in Q1 2026, and -$441.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 53.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.26 Mn
Mar 31, 2026 98.56 Mn
Dec 31, 2025 -441.37 Mn
Sep 30, 2025 26.58 Mn
Jun 30, 2025 73.07 Mn
Mar 31, 2025 20.10 Mn
Dec 31, 2024 -26.62 Mn
Sep 30, 2024 47.67 Mn
Jun 30, 2024 77.94 Mn
Mar 31, 2024 63.99 Mn
Dec 31, 2023 59.56 Mn
Sep 30, 2023 -314.07 Mn
Jun 30, 2023 45.83 Mn
Mar 31, 2023 2.99 Mn
Dec 31, 2022 -168.21 Mn
Sep 30, 2022 -5.06 Mn
Jun 30, 2022 -4.58 Mn
Mar 31, 2022 -4.88 Mn
Dec 31, 2021 -3.55 Mn
Sep 30, 2021 -57.64 Mn